According to MarketsandMarkets™, the global In vitro diagnostics (IVD) market is projected to grow from USD 109.1 billion in 2025 to USD 157.6 billion by 2030, registering a CAGR of 7.6% during the forecast period. The market is witnessing steady expansion, fueled by increasing awareness around early disease detection, rising demand for routine screening, and growing adoption of advanced diagnostic technologies.
Browse 882 market data Tables and 67 Figures spread through 739 Pages and in-depth TOC on “In Vitro Diagnostics Market”.
Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=703
Governments worldwide are investing in healthcare infrastructure and implementing large-scale screening programs to improve access to diagnostic testing. At the same time, the shift toward personalized medicine is accelerating the demand for high-precision diagnostic solutions tailored to individual patient profiles. Advances in genetic testing, next-generation sequencing, and automation are enhancing the speed, accuracy, and efficiency of diagnostic workflows.
Reagents & Kits Segment to Register Fastest Growth
By product and service, the reagents & kits segment is expected to record the highest growth rate during the forecast period. Increasing reliance on rapid, accurate, and easy-to-use diagnostic solutions is driving demand across laboratories and hospitals.
Continuous innovations are improving the sensitivity and usability of reagents and kits, making them critical components in modern diagnostics. Additionally, the rise of personalized medicine is fueling demand for specialized diagnostic kits designed to detect specific genetic markers and conditions. Stringent regulatory standards are further strengthening market confidence and accelerating adoption.
Blood-Based Specimens Continue to Dominate
By specimen, blood, serum, and plasma samples accounted for the largest market share in 2024. These specimen types remain the gold standard in diagnostics due to their reliability and wide applicability across multiple disease areas, including diabetes, infectious diseases, oncology, and cardiovascular conditions.
Their compatibility with advanced testing platforms such as immunoassays, molecular diagnostics, and genetic testing ensures continued dominance in both routine and complex diagnostic procedures.
North America Leads Global Market
North America dominated the global IVD market in 2024, supported by rapid adoption of advanced diagnostic technologies such as high-throughput systems, lab-on-a-chip platforms, and digital health integration.
The region’s healthcare ecosystem is increasingly focused on precision medicine, leveraging complex diagnostic tests to identify genetic, protein, and metabolic markers. Rising healthcare expenditure and strong institutional support further contribute to market growth.
Leading industry players, including Danaher, F. Hoffmann-La Roche Ltd, Abbott, Siemens Healthineers AG, and Thermo Fisher Scientific Inc., continue to drive innovation through robust R&D pipelines, strategic collaborations, and extensive distribution networks.
Speak To Analyst:- https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=703
Competitive Landscape
Key players in the global in vitro diagnostics market include Danaher (US), F. Hoffmann-La Roche Ltd (Switzerland), Abbott (US), Siemens Healthineers AG (Germany), Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Hologic, Inc. (US), Bio-Rad Laboratories, Inc. (US), bioMérieux (France), Sysmex Corporation (Japan), Revvity (US), Becton, Dickinson and Company (US), Agilent Technologies, Inc. (US), Qiagen (Netherlands), DiaSorin S.p.A. (Italy), Grifols, S.A. (Spain), Werfen (Spain), and QuidelOrtho Corporation (US), among others.
These companies are actively focusing on innovation, portfolio expansion, and strategic partnerships to strengthen their market presence and meet the evolving demand for advanced diagnostic solutions.
Related Reports:
US In Vitro Diagnostics Market – Global Forecast to 2031
IVD Quality Control Market – Global Forecast to 2030
Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/ivd-in-vitro-diagnostics-market-703.html
Press Release Distributed by ABNewswire.com
To view the original version on ABNewswire visit: In Vitro Diagnostics Market to Reach $157.6 Billion by 2030, Driven by Rising Demand for Early Disease Detection and Personalized Medicine
